Raymond James & Associates’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
Other funds holding EXC
Raymond James & Associates's EXC Position: Q3 2024 in Review
Raymond James & Associates reduced its Exelon (EXC) stake by 18% in Q3 2024, selling an estimated $3.72M and leaving 444,003 shares worth $18M. The position accounts for 0.01% of the portfolio, ranked #875.
Raymond James & Associates first reported a position in EXC in Q2 2013 and has held it in 46 quarters since. The position peaked at $38.9M in Q4 2018. 1,053 funds tracked by Wall St. Rank hold EXC as of Q3 2024.
- Raymond James & Associates held 444,003 shares of Exelon worth $18M as of Q3 2024.
- Raymond James & Associates sold 98,908 Exelon shares in Q3 2024, an estimated $3.72M.
- Exelon made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #875 holding.
- Raymond James & Associates first reported a position in Exelon in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's Exelon position peaked at $38.9M in Q4 2018.
- 1,053 funds tracked by Wall St. Rank held Exelon as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.